NCT03940352 HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS) Status TERMINATED Phase PHASE1
NCT03938454 A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism Status COMPLETED Phase PHASE2
NCT03930641 Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration Status COMPLETED Phase PHASE3
NCT03927690 Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema Status COMPLETED Phase PHASE2
NCT03926611 This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines Status COMPLETED Phase PHASE2
NCT03918980 Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064 Status COMPLETED Phase PHASE1
NCT03917472 Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT03917459 COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure Status COMPLETED Phase PHASE3
NCT03909295 An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan. Status TERMINATED Phase PHASE3
NCT03907878 A Safety and Efficacy Study of Ligelizumab in the Treatment of CSU in Japanese Patients Inadequately Controlled With H1- Antihistamines Status COMPLETED Phase PHASE3
NCT03906292 Frontline Asciminib Combination in Chronic Phase CML Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03905525 Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome Status COMPLETED Phase PHASE2
NCT03896152 Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Status COMPLETED Phase PHASE2
NCT03894020 GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) Status TERMINATED Phase N/A
NCT03891953 Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03881696 Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants Status COMPLETED Phase PHASE3
NCT03876769 Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03876028 Study of Tisagenlecleucel in Combination With Ibrutinib in r/r Diffuse Large B-cell Lymphoma Patients Status TERMINATED Phase PHASE1